These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29754101)

  • 1. Isolated tactile hallucination in a patient with Parkinson's disease: Quetiapine conquers the snakes and stones.
    Lenka A; Reddy YCJ; Pal PK
    Asian J Psychiatr; 2018 Jun; 35():34-35. PubMed ID: 29754101
    [No Abstract]   [Full Text] [Related]  

  • 2. Two cases of musical hallucination successfully treated with quetiapine.
    Kitamura H; Saito M; Someya T
    Psychiatry Clin Neurosci; 2017 Nov; 71(11):789. PubMed ID: 28853197
    [No Abstract]   [Full Text] [Related]  

  • 3. Quetiapine for Parkinson's Disease psychosis: Evidence-based medicine versus expert belief: A case study.
    Friedman JH
    Mov Disord; 2018 Jul; 33(7):1186-1187. PubMed ID: 29644756
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacotherapy in Bipolar Depression Comorbid With Parkinson's Disease: A Case Report.
    Wang JK; Lee HC
    J Neuropsychiatry Clin Neurosci; 2015; 27(3):e213. PubMed ID: 26222973
    [No Abstract]   [Full Text] [Related]  

  • 5. Visual hallucinations in PD.
    Frucht SJ; Bernsohn L
    Neurology; 2002 Dec; 59(12):1965. PubMed ID: 12499491
    [No Abstract]   [Full Text] [Related]  

  • 6. Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine.
    Moreno GM; Gandhi R; Lessig SL; Wright B; Litvan I; Nahab FB
    Neurology; 2018 Oct; 91(17):797-799. PubMed ID: 30258020
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term evaluation of the effect of quetiapine on hallucinations, delusions and motor function in advanced Parkinson disease.
    Mancini F; Tassorelli C; Martignoni E; Moglia A; Nappi G; Cristina S; Pacchetti C
    Clin Neuropharmacol; 2004; 27(1):33-7. PubMed ID: 15090935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study.
    Fernandez HH; Okun MS; Rodriguez RL; Malaty IA; Romrell J; Sun A; Wu SS; Pillarisetty S; Nyathappa A; Eisenschenk S
    Int J Neurosci; 2009; 119(12):2196-205. PubMed ID: 19916848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological interventions for psychosis in Parkinson's disease patients.
    Friedman JH
    Expert Opin Pharmacother; 2018 Apr; 19(5):499-505. PubMed ID: 29494265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Threatening auditory hallucinations and Cotard syndrome in Parkinson disease.
    Factor SA; Molho ES
    Clin Neuropharmacol; 2004; 27(5):205-7. PubMed ID: 15602098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristic of psychiatric symptoms in Acute Intermittent Porphyria (AIP): A report of a pair of identical twins.
    Tay JL; Lal M
    Asian J Psychiatr; 2017 Oct; 29():192-193. PubMed ID: 28704787
    [No Abstract]   [Full Text] [Related]  

  • 12. Quetiapine (Seroquel) in the treatment of psychosis in patients with Parkinson's disease.
    Parsa MA; Bastani B
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):216-9. PubMed ID: 9608412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quetiapine Relieved Pisa Syndrome in Patient With Parkinson Disease.
    Zhao J; Wang Q; Sun H; Liu X; Leng B; Wang T
    Clin Neuropharmacol; 2020; 43(6):171-174. PubMed ID: 32991348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Follow-up of Parkinson's Disease With Newly Prescribed Quetiapine.
    Weintraub D; Chiang C; Kim HM; Wilkinson J; Marras C; Stanislawski B; Mamikonyan E; Kales HC
    Mov Disord; 2020 Sep; 35(9):1690-1692. PubMed ID: 32725640
    [No Abstract]   [Full Text] [Related]  

  • 15. Current Understanding of Psychosis in Parkinson's Disease.
    Ojo OO; Fernandez HH
    Curr Psychiatry Rep; 2016 Oct; 18(10):97. PubMed ID: 27629356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: Positive impact on long-term worsening.
    Goetz CG; Fan W; Leurgans S
    Mov Disord; 2008 Aug; 23(11):1541-5. PubMed ID: 18567004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mirtazapine improves visual hallucinations in Parkinson's disease: a case report.
    Tagai K; Nagata T; Shinagawa S; Tsuno N; Ozone M; Nakayama K
    Psychogeriatrics; 2013 Jun; 13(2):103-7. PubMed ID: 23909968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible case of peduncular hallucinosis in a patient with Parkinson's disease successfully treated with quetiapine.
    Spiegel DR; Lybeck B; Angeles V
    J Neuropsychiatry Clin Neurosci; 2009; 21(2):225-6. PubMed ID: 19622697
    [No Abstract]   [Full Text] [Related]  

  • 19. [Three patients with Parkinson's disease whose therapeutic levels were successfully improved after administration of quetiapine for suppression of psychosis].
    Kodama R; Morita S; Miwa H; Kondo T
    No To Shinkei; 2003 May; 55(5):413-7. PubMed ID: 12833883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case report of pancytopenia with quetiapine use.
    Iraqi A
    Am J Geriatr Psychiatry; 2003; 11(6):694. PubMed ID: 14609812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.